This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Historx, Inc., Novartis Ag. Active years: 2011-2016.
Company Filing History:
Years Active: 2011-2016
Title: The Innovative Contributions of Dylan M Reilly
Introduction
Dylan M Reilly is a notable inventor based in Middletown, CT (US). He has made significant contributions to the field of biomarker expression and imaging technology. With a total of 5 patents to his name, Reilly's work has advanced the understanding and application of these technologies in various industries.
Latest Patents
One of Reilly's latest patents is focused on the reproducible quantification of biomarker expression. This method allows for consistent scoring of biomarker expression in tissue samples, independent of the instrument used, its location, or the operator. Another significant invention is related to automatic exposure time selection for imaging tissue. This system optimizes the dynamic range of digital images by automatically adjusting the exposure time based on the frequency distribution of pixel intensity values. The result is an improved image quality that enhances the visibility of the subject.
Career Highlights
Throughout his career, Dylan M Reilly has worked with prominent companies such as Historx, Inc. and Novartis AG. His experience in these organizations has contributed to his expertise in the field and has allowed him to develop innovative solutions that address complex challenges in biomarker analysis and imaging.
Collaborations
Reilly has collaborated with talented individuals in his field, including Jason Christiansen and Mark D Gustavson. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Dylan M Reilly's contributions to innovation in biomarker expression and imaging technology are noteworthy. His patents reflect a commitment to advancing scientific understanding and improving practical applications in these areas.
